Core Viewpoint - Hebei Caike New Materials Technology Co., Ltd. (referred to as "Caike Technology") is facing scrutiny from the Beijing Stock Exchange regarding the sustainability of its high growth, sales authenticity, and fairness of related party transactions, particularly in light of a significant revenue increase driven by short-term orders following the bankruptcy of German competitor Huber [1][2]. Financial Performance - For 2024, Caike Technology projects revenue of 454 million yuan and a net profit of 113 million yuan, representing year-on-year growth of 20.6% and 44.0%, respectively [1]. - The revenue increase is largely attributed to the demand surge for DMSS and DATA intermediates due to Huber's market exit, raising concerns about the stability of this demand and potential post-2025 performance decline [1]. Customer and Revenue Recognition - Wenzhou Jinyuan remains the largest customer, accounting for 29%-32% of total revenue. The company initially recognized revenue on a "ship first, contract later" basis, which was later changed to an "annual framework + monthly settlement" model starting May 2025 [1][2]. - Regulatory authorities have requested detailed information on revenue recognition practices and the effectiveness of internal controls related to sales to Wenzhou Jinyuan [2]. Related Party Transactions - From 2022 to the first half of 2025, the company’s related party procurement amounts were 69.12 million yuan, 75.16 million yuan, 66.76 million yuan, and 35.67 million yuan, constituting 28%-33% of operating costs [2]. - The majority of related party purchases were for steam and wastewater treatment services from a related entity, raising questions about the rationale and fairness of these transactions [2]. Capital Expenditure and Production Capacity - The company plans to raise 210 million yuan for various expansion projects, including increasing production capacity for DMS, DMSS, and DATA [3]. - Despite the anticipated high growth in 2024, production capacity utilization rates for major products are expected to drop significantly to below 70% in the first half of 2025 [3][4]. Production Metrics - The production capacity utilization rates for DMSS, DMAS, and DATA in the first half of 2025 are projected to be 63.46%, 69.58%, and 62.07%, respectively, indicating a substantial decline from previous years [4].